当前位置:首页 - 行情中心 - 华东医药(000963) - 财务分析

华东医药

(000963)

  

流通市值:537.88亿  总市值:538.93亿
流通股本:17.51亿   总股本:17.54亿

华东医药(000963)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润21.94亿元,每股收益1.25元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益2093918.41万元,未分配利润1517046.74万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产3399268.55万元,负债1305350.14万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入30,394,530,509.5120,385,344,288.8110,114,531,331.7737,714,587,458.01
营业总成本27,539,505,233.918,443,622,876.249,111,221,456.7734,568,570,175.18
营业利润2,708,572,838.61,798,460,883.53953,939,762.933,061,454,274.23
利润总额2,688,109,670.731,785,135,155.34949,279,771.073,031,124,248.98
净利润2,193,548,822.361,439,855,714.43759,925,490.332,532,625,701.36
其他综合收益-3,888,970.61-8,889,448.01-31,351,409.53-40,784,410.62
综合收益总额2,189,659,851.751,430,966,266.42728,574,080.82,491,841,290.74
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计19,587,988,033.0918,728,856,472.8518,314,948,187.3417,567,863,482.97
非流动资产合计14,404,697,476.3914,227,143,743.2113,800,252,579.9213,624,339,923.87
资产总计33,992,685,509.4832,956,000,216.0632,115,200,767.2631,192,203,406.84
流动负债合计11,643,411,900.1311,358,018,205.4110,627,556,249.3310,152,812,095.73
非流动负债合计1,410,089,498.231,414,973,512.11,567,111,480.781,862,949,927.96
负债合计13,053,501,398.3612,772,991,717.5112,194,667,730.1112,015,762,023.69
归属于母公司股东权益合计20,298,210,883.6619,532,395,598.1619,314,073,760.9718,577,919,237.39
股东权益合计20,939,184,111.1220,183,008,498.5519,920,533,037.1519,176,441,383.15
负债和股东权益合计33,992,685,509.4832,956,000,216.0632,115,200,767.2631,192,203,406.84
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计33,330,003,956.9822,779,476,575.410,126,143,435.5540,637,718,289.85
经营活动现金流出小计31,080,726,073.1720,757,732,826.7510,372,296,205.7138,255,865,621.25
经营活动产生的现金流量净额2,249,277,883.812,021,743,748.65-246,152,770.162,381,852,668.6
投资活动现金流入小计225,228,902.82230,301,405.844,462,257.72121,638,643.17
投资活动现金流出小计1,173,150,395.68807,988,433.22484,517,570.582,557,236,232.75
投资活动产生的现金流量净额-947,921,492.86-577,687,027.42-440,055,312.86-2,435,597,589.58
筹资活动现金流入小计4,354,909,040.172,606,267,337.21966,338,373.665,149,368,399.06
筹资活动现金流出小计5,573,224,030.053,532,758,944.761,815,751,017.335,249,078,772.19
筹资活动产生的现金流量净额-1,218,314,989.88-926,491,607.55-849,412,643.67-99,710,373.13
汇率变动对现金及现金等价物的影响-20,487,569.218,950,719.044,528,971.51-9,774,641.73
现金及现金等价物净增加额62,553,831.86526,515,832.72-1,531,091,755.18-163,229,935.84
期末现金及现金等价物余额3,479,464,534.193,943,426,535.051,885,818,947.153,416,910,702.33
最新报告期:2024-02-01
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
国泰君安丁丹,吴晗1.631.932.292024-02-01
国泰君安丁丹,吴晗1.631.932.292024-02-01
国金证券袁维1.622.012.432024-01-31
国金证券袁维1.622.012.432024-01-31
TOP↑